STATCenter·
STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries
The model is a test of Trump's most-favored nation approach to drug pricing, though its impact is likely to be limited.
Read at STAT →
The model is a test of Trump's most-favored nation approach to drug pricing, though its impact is likely to be limited.

<iframe src="https://statesidedaily.com/embed/cluster/6c6355d7868f0c45a2e6110596edee69ed3f9b9c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries"></iframe>
